ArticleSmall methods2025
Facet Control of Gold Nanoplate on Sacrificial Transition Metal Dichalcogenides.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Facet Control of Gold Nanoplate on Sacrificial Transition Metal Dichalcogenides.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The synthesis of gold nanostructures (AuNS) is a classical topic, celebrated for the exceptional capabilities these structures exhibit across a spectrum of applications. Controlling the morphology and location of gold nanostructures on a large scale is typically a complex task. For example, the thermal annealing method necessitates precise management of the wetting behavior between the gold nanofilm and the substrate during heating to facilitate the transformation of the gold nanofilm into gold nanostructures. Here, the study innovatively applies 2D monolayer MoS
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.